Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
370 GBX | 0.00% | -2.12% | +4.96% |
May. 08 | MaxCyte Shares Rise Sharply After Q1 Results Beat | MT |
May. 08 | MaxCyte shares rise amid double-digit revenue increase | AN |
Financials (USD)
Sales 2024 * | 36.42M | Sales 2025 * | 46.63M | Capitalization | 491M |
---|---|---|---|---|---|
Net income 2024 * | -48M | Net income 2025 * | -45M | EV / Sales 2024 * | 9.39 x |
Net cash position 2024 * | 150M | Net cash position 2025 * | 120M | EV / Sales 2025 * | 7.96 x |
P/E ratio 2024 * |
-10.3
x | P/E ratio 2025 * |
-11.2
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.86% |
Latest transcript on MaxCyte, Inc.
1 day | -1.33% | ||
1 week | -0.54% | ||
Current month | +25.42% | ||
1 month | +18.21% | ||
3 months | +2.78% | ||
6 months | +9.63% | ||
Current year | +4.96% |
Managers | Title | Age | Since |
---|---|---|---|
Maher Masoud
CEO | Chief Executive Officer | 49 | - |
Douglas Swirsky
DFI | Director of Finance/CFO | 54 | 23-03-26 |
James Brady
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Balthrop
BRD | Director/Board Member | 67 | 22-11-30 |
Art Mandell
BRD | Director/Board Member | 71 | 06-04-30 |
Will Brooke
BRD | Director/Board Member | 68 | 04-02-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 12 M€ | -.--% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 370 | 0.00% | 25 934 |
24-05-20 | 370 | -1.33% | 2,624 |
24-05-17 | 375 | 0.00% | 12,710 |
24-05-16 | 375 | +1.35% | 18,299 |
24-05-15 | 370 | -2.12% | 44,892 |
Delayed Quote London S.E., May 20, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.96% | 491M | |
+11.91% | 227B | |
+15.46% | 198B | |
+18.58% | 142B | |
+30.36% | 111B | |
+0.65% | 64.16B | |
+17.74% | 54.1B | |
+5.82% | 51.41B | |
+11.23% | 45.32B | |
+5.73% | 37.32B |
- Stock Market
- Equities
- MXCT Stock